Maternal Medication, Drug Use, and Breastfeeding

Child and Adolescent Psychiatric Clinics of North America

Volumn 24, Issue 1, 2015, Pages 1-20

  Rowe, Hilary ^a   Baker, Teresa ^b   Hale, Thomas W ^b  

^a FRASER HEALTH AUTHORITY   (Canada)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Antidepressants; Antipsychotics; Breastfeeding; Infant exposure; Medications

Indexed keywords

ALCOHOL; ALPRAZOLAM; ANALGESIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CANNABIS; CITALOPRAM; CLONAZEPAM; DESVENLAFAXINE; DEXAMPHETAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLURAZEPAM; FLUVOXAMINE; LORAZEPAM; METHYLPHENIDATE; MIDAZOLAM; NICOTINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZOLPIDEM; ZOPICLONE; COTININE; PRESCRIPTION DRUG; STREET DRUG;

ANXIETY; ARTICLE; BEHAVIOR DISORDER; BIPOLAR DISORDER; BREAST FEEDING; BREAST MILK; CLINICAL DECISION MAKING; COLIC; CRYING; DEPRESSION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MILK LEVEL; DRUG PENETRATION; DRUG TRANSPORT; DRUG USE; FEEDING; HUMAN; HYPERTENSION; INFECTION; INSOMNIA; MATERNAL CARE; MILK PRODUCTION; NAUSEA; PAIN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PSYCHOSIS; PUERPERAL DEPRESSION; SIDE EFFECT; SMOKING; SOMNOLENCE; TERATOGENICITY; WEIGHT REDUCTION; ADVERSE DRUG REACTION; CHEMISTRY; FEMALE; INFANT; NEWBORN; RISK ASSESSMENT; UNITED STATES;

BREAST FEEDING; CAFFEINE; COTININE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ETHANOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MILK, HUMAN; NICOTINE; PRESCRIPTION DRUGS; RISK ASSESSMENT; STREET DRUGS; UNITED STATES;

EID: 84927667012     PISSN: 10564993     EISSN: 15580490     Source Type: Journal    
DOI: 10.1016/j.chc.2014.09.005     Document Type: Review

References (122)

1. Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion. Breastfeeding report card, United States 2013. Centers for Disease Control Report Card [Internet]. 2013. p. 1-8. Available at: . Accessed July 26, 2014. http://www.cdc.gov/breastfeeding/pdf/2013breastfeedingreportcard.pdf.
2. Stultz E.E., Stokes J.L., Shaffer M.L., et al. Extent of medication use in breastfeeding women. Breastfeed Med 2007, 2(3):145-151.
3. Hale T.W. Medication and mothers' milk 2010, Hale Publishing, Amarillo (TX). 14th edition.
4. Hale T.W., Hartmann P.E. Textbook of human lactation 2007, Hale Publishing LPL, Amarillo (TX).
5. Bennett P.N. Drugs and human lactation 1996, Elsevier, Amsterdam.
6. Centers for Disease Control and Prevention (CDC) Prevalence of self-reported postpartum depressive symptoms-17 states, 2004-2005. MMWR Morb Mortal Wkly Rep 2008, 57(14):361-366.
7. Stowe Z.N., Hostetter A.L., Owens M.J., et al. The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations. JClin Psychiatry 2003, 64(1):73-80.
8. Hagg S., Granberg K., Carleborg L. Excretion of fluvoxamine into breast milk. Br J Clin Pharmacol 2000, 49(3):286-288.
9. Ohman R., Hagg S., Carleborg L., et al. Excretion of paroxetine into breast milk. JClin Psychiatry 1999, 60(8):519-523.
10. Kristensen J.H., Ilett K.F., Hackett L.P., et al. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol 1999, 48(4):521-527.
11. Kelly L.E., Poon S., Madadi P., et al. Neonatal benzodiazepines exposure during breastfeeding. JPediatr 2012, 161:448-451.
12. Kanto J.H. Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations. Drugs 1982, 23(5):354-380.
13. Rindi V. La eliminazione degli antistaminici di sintesi con il latte e l'azione latto-goga de questi. Riv Ital Ginecol 1951, 34:147-157.
14. Matheson I., Sande H.A., Gaillot J. The excretion of zopiclone into breast milk. Br J Clin Pharmacol 1990, 30(2):267-271.
15. Hill R.C., McIvor R.J., Wojnar-Horton R.E., et al. Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding. JClin Psychopharmacol 2000, 20(2):285-286.
16. Croke S., Buist A., Hackett L.P., et al. Olanzapine excretion in human breast milk: estimation of infant exposure. Int J Neuropsychopharmacol 2002, 5(3):243-247.
17. Rampono J., Kristensen J.H., Ilett K.F., et al. Quetiapine and breast feeding. Ann Pharmacother 2007, 41:711-714.
18. Wiles D.H., Orr M.W., Kolakowska T. Chlorpromazine levels in plasma and milk of nursing mothers. Br J Clin Pharmacol 1978, 5(3):272-273.
19. Hackett L.P., Kristensen J.H., Hale T.W., et al. Methylphenidate and breast-feeding. Ann Pharmacother 2006, 40(10):1890-1891.
20. Ilett K.F., Hackett L.P., Kristensen J.H., et al. Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder. Br J Clin Pharmacol 2006, 10.1111/j.1365-2125.2006.02767.x.
21. von Unruh G.E., Froescher W., Hoffmann F., et al. Valproic acid in breast milk: how much is really there?. Ther Drug Monit 1984, 6(3):272-276.
22. Tomson T., Ohman I., Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia 1997, 38(9):1039-1041.
23. Newport D.J., Pennell P.B., Calamaras M.R., et al. Lamotrigine in breast milk and nursing infants: determination of exposure. Pediatrics 2008, 122(1):e223-e231.
24. Ohman I., Vitols S., Luef G., et al. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 2002, 43(10):1157-1160.
25. Mennella J.A., Beauchamp G.K. The transfer of alcohol to human milk. Effects on flavor and the infant's behavior. NEngl J Med 1991, 325(14):981-985. [see comments].
26. Mennella J.A. Regulation of milk intake after exposure to alcohol in mothers' milk. Alcohol Clin Exp Res 2001, 25(4):590-593.
27. Cobo E. Effect of different doses of ethanol on the milk-ejecting reflex in lactating women. Am J Obstet Gynecol 1973, 115(6):817-821.
28. Ho E., Collantes A., Kapur B.M., et al. Alcohol and breast feeding: calculation of time to zero level in milk. Biol Neonate 2001, 80(3):219-222.
29. Perez-Reyes M., Wall M.E. Presence of delta9-tetrahydrocannabinol in human milk. NEngl J Med 1982, 307(13):819-820. [letter].
30. Tennes K., Avitable N., Blackard C., et al. Marijuana: prenatal and postnatal exposure in the human. NIDA Res Monogr 1985, 59:48-60.
31. Astley S.J., Little R.E. Maternal marijuana use during lactation and infant development at one year. Neurotoxicol Teratol 1990, 12(2):161-168.
32. Jutras-Aswad D., DiNieri J., Harkany T., et al. Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. Eur Arch Psychiatry Clin Neurosci 2009, 259:395-412.
33. Ilett K.F., Hale T.W., Page-Sharp M., et al. Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk. Clin Pharmacol Ther 2003, 74(6):516-524.
34. Tyrala E.E., Dodson W.E. Caffeine secretion into breast milk. Arch Dis Child 1979, 54(10):787-800.
35. Ryu J.E. Caffeine in human milk and in serum of breast-fed infants. Dev Pharmacol Ther 1985, 8(6):329-337.
36. Weibert R.T., Townsend R.J., Kaiser D.G., et al. Lack of ibuprofen secretion into human milk. Clin Pharm 1982, 1(5):457-458.
37. Bitzen P.O., Gustafsson B., Jostell K.G., et al. Excretion of paracetamol in human breast milk. Eur J Clin Pharmacol 1981, 20(2):123-125.
38. Jamali F., Stevens D.R. Naproxen excretion in milk and its uptake by the infant. Drug Intell Clin Pharm 1983, 17(12):910-911.
39. Edwards J.E., Rudy A.C., Wermeling D.P., et al. Hydromorphone transfer into breast milk after intranasal administration. Pharmacotherapy 2003, 23(2):153-158.
40. Sauberan J.B., Anderson P.O., Lane J.R., et al. Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum pain. Obstet Gynecol 2011, 117(3):611-617.
41. Bodley V., Powers D. Long-term treatment of a breastfeeding mother with fluconazole-resolved nipple pain caused by yeast: a case study. JHum Lact 1997, 13(4):307-311.
42. Meyer D., Tobias J.D. Adverse effects following the inadvertent administration of opioids to infants and children. Clin Pediatr 2005, 44:499-503.
43. Feilberg V.L., Rosenborg D., Broen C.C., et al. Excretion of morphine in human breast milk. Acta Anaesthesiol Scand 1989, 33(5):426-428.
44. Koren G., Cairns J., Chitayat D., et al. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 2006, 368(9536):704.
45. Lam J., Kelly L., Ciszkowski C., et al. Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. JPediatr 2012, 160:33-37.
46. Sandstrom B., Regardh C.G. Metoprolol excretion into breast milk. Br J Clin Pharmacol 1980, 9(5):518-519.
47. Taylor E.A., Turner P. Anti-hypertensive therapy with propranolol during pregnancy and lactation. Postgrad Med J 1981, 57:427-430.
48. Lunell N.O., Kulas J., Rane A. Transfer of labetalol into amniotic fluid and breast milk in lactating women. Eur J Clin Pharmacol 1985, 28(5):597-599.
49. Schimmel M.S., Eidelman A.I., Wilschanski M.A., et al. Toxic effects of atenolol consumed during breast feeding. JPediatr 1989, 114:476-478.
50. Boutroy M.J., Bianchetti G., Dubruc C., et al. To nurse when receiving acebutolol: is it dangerous for the neonate?. Eur J Clin Pharmacol 1986, 30(6):737-739.
51. Ehrenkranz R.A., Ackerman B.A., Hulse J.D. Nifedipine transfer into human milk. JPediatr 1989, 114(3):478-480.
52. Anderson P., Bondesson U., Mattiasson I., et al. Verapamil and norverapamil in plasma and breast milk during breast feeding. Eur J Clin Pharmacol 1987, 31:625-627.
53. Okada M., Inoue H., Nakamura Y., et al. Excretion of diltiazem in human milk. NEngl J Med 1985, 312(15):992-993.
54. Devlin R.G. Selective resistance to the passage of captopril into human milk. Clin Pharmacol Ther 1980, 27:250.
55. Redman C.W., Kelly J.G., Cooper W.D. The excretion of enalapril and enalaprilat in human breast milk. Eur J Clin Pharmacol 1990, 38(1):99.
56. Miller M.E., Cohn R.D., Burghart P.H. Hydrochlorothiazide disposition in a mother and her breast-fed infant. JPediatr 1982, 101(5):789-791.
57. Healy M. Suppressing lactation with oral diuretics. Lancet 1961, 277(1790):1353-1354.
58. Courtney T.P., Shaw R.W. Excretion of famotidine in breast milk. Br J Clin Pharmacol 1988, 26:639.
59. Kearns G.L., McConnell R.F., Trang J.M., et al. Appearance of ranitidine in breast milk following multiple dosing. Clin Pharm 1985, 4(3):322-324.
60. Marshall J.K., Thompson A.B., Armstrong D. Omeprazole for refractory gastroesophageal reflux disease during pregnancy and lactation. Can J Gastroenterol 1998, 12(3):225-227.
61. Plante L., Ferron G.M., Unruh M., et al. Excretion of pantoprazole in human breast. JReprod Med 2004, 49(10):825-827.
62. Guikontes E., Spantideas A., Diakakis J. Ondansetron and hyperemesis gravidarum. Lancet 1992, 340:1223.
63. Khalil S.N., Roth A.G., Cohen I.T., et al. Adouble-blind comparison of intravenous ondansetron and placebo for preventing postoperative emesis in 1 to 24 month old pediatric patients after surgery under general anesthesia. Anesth Analg 2005, 101:356-361.
64. Kafetzis D.A., Siafas C.A., Georgakopoulos P.A., et al. Passage of cephalosporins and amoxicillin into the breast milk. Acta Paediatr Scand 1981, 70(3):285-288.
65. Benyamini L., Merlob P., Stahl B., et al. The safety of amoxicillin/clavulanic acid and cefuroxime during lactation. Ther Drug Monit 2005, 27:499-502.
66. Morganti G., Ceccarelli G., Ciaffi G. Comparative concentrations of a tetracycline antibiotic in serum and maternal milk. Antibiotica 1968, 6(3):216-223. [in Multiple languages].
67. Ghaffar F., McCracken G.H. Quinolones in pediatrics. Quinolone antimicrobial agents 2003, 343-354. ASM Press, Washington, DC. 3rd edition. D.C. Hooper, E. Rubinstein (Eds.).
68. Giamarellou H., Kolokythas E., Petrikkos G., et al. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 1989, 87(5A):49S-51S.
69. Shetty A.K. Tetracyclines in pediatrics revisited. Clin Pediatr 2002, 41:203-209.
70. Posner A.C., Prigot A., Konicoff N.G. Further observations on the use of tetracycline hydrochloride in prophylaxis and treatment of obstetric infections. Antibiotics annual 1954-1955 1955, Medical Encyclopedia, New York.
71. von Keutz E., Ruhl-Fehlert C., Drommer W., et al. Effects of ciprofloxacin on joint cartilage in immature dogs immediately after dosing and after a 5-month treatment-free period. Arch Toxicol 2004, 78:418-424.
72. Schwebke J.R. Metronidazole: utilization in the obstetric and gynecologic patient. Sex Transm Dis 1995, 22(6):370-376.
73. Passmore C.M., McElnay J.C., Rainey E.A., et al. Metronidazole excretion in human milk and its effect on the suckling neonate. Br J Clin Pharmacol 1988, 26(1):45-51.
74. Erickson S.H., Oppenheim G.L., Smith G.H. Metronidazole in breast milk. Obstet Gynecol 1981, 57(1):48-50.
75. Putter J., Satravaha P., Stockhausen H. Quantitative analysis of the main metabolites of acetylsalicylic acid. Comparative analysis in the blood and milk of lactating women (author's transl). ZGeburtshilfe Perinatol 1974, 178(2):135-138. [in German].
76. Briggs G.G., Ambrose P.J., Nageotte M.P., et al. Excretion of metformin into breast milk and the effect on nursing infants. Obstet Gynecol 2005, 105(6):1437-1441.
77. Feig D.S., Briggs G.G., Kraemer J.M., et al. Transfer of glyburide and glipizide into breast milk. Diabetes Care 2005, 28(8):1851-1855.
78. Novo Nordisk Canada Inc. Pharmaceutical manufacturer product monograph: human insulin Novolin ge. 2011.
79. Kennedy K.I., Short R.V., Tully M.R. Premature introduction of progestin-only contraceptive methods during lactation. Contraception 1997, 55(6):347-350.
80. Espey E., Ogburn T., Leeman L., et al. Effect of progestin compared with combined oral contraceptive pills on lactation. Obstet Gynecol 2012, 119(1):5-13.
81. Croxatto H.B., Diaz S., Peralta O., et al. Fertility regulation in nursing women: IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth. Contraception 1983, 27(1):13-25.
82. Queenan J. Exploring contraceptive options for breastfeeding mothers. Obstet Gynecol 2012, 119(1):1-2.
83. Cox D.B., Owens R.A., Hartmann P.E. Blood and milk prolactin and the rate of milk synthesis in women. Exp Physiol 1996, 81(6):1007-1020.
84. Kauppila A., Kivinen S., Ylikorkala O. Adose response relation between improved lactation and metoclopramide. Lancet 1981, 1(8231):1175-1177.
85. Kauppila A., Arvela P., Koivisto M., et al. Metoclopramide and breast feeding: transfer into milk and the newborn. Eur J Clin Pharmacol 1983, 25:819-823.
86. US Food and Drug Administration. FDA talk paper: FDA warns against women using unapproved drug, domperidone, to increase milk production 2004. Available at: . Accessed July 25, 2014. http://www.fda.gov/drugs/drugsafety/informationbydrugclass/ucm173886.htm.
87. Lexi-Interact [Internet]. Lexi-Comp, Inc. Accessed July 25, 2014.
88. da Silva O.P., Knoppert D.C., Angelini M.M., et al. Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial. CMAJ 2001, 164(1):17-21.
89. Reeder C., Legrand A., O'Conner-Von S. The effect of fenugreek on milk production and prolactin levels in mothers of premature infants. JHum Lact 2011, 27:74. [abstract].
90. Rampono J., Kristensen J.H., Hackett L.P., et al. Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants. Br J Clin Pharmacol 2000, 50(10):263-268.
91. Schmidt K., Olesen O.V., Jensen P.N. Citalopram and breast-feeding: serum concentration and side effects in the infant. Biol Psychiatry 2000, 47(2):164-165.
92. Frannsen E.J. Citalopram serum and milk levels in mother and infant during lactation. Ther Drug Monit 2006, 28(1):2-4.
93. Taddio A., Ito S., Koren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. JClin Pharmacol 1996, 36(1):42-47.
94. Lester B.M., Cucca J., Andreozzi L., et al. Possible association between fluoxetine hydrochloride and colic in an infant. JAm Acad Child Adolesc Psychiatry 1993, 32(6):1253-1255.
95. Rampono J., Hackett L.P., Kristensen J.H., et al. Transfer of escitalopram and its metabolite demethylescitalopram into breast milk. Br J Clin Pharmacol 2006, 62(3):316-322.
96. Newport D.J., Ritchie J.C., Knight B.T., et al. Venlafaxine in human breast milk and nursing infant plasma: determination of exposure. JClin Psychiatry 2009, 70(9):1304-1310.
97. Rampono J., Teoh S., Hackett L.P., et al. Estimation of desvenlafaxine transfer into milk and infant exposure during its use in lactating women with postnatal depression. Arch Womens Ment Health 2011, 14(1):49-53.
98. Lobo E.D., Loghin C., Knadler M.P., et al. Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women. Clin Pharmacokinet 2008, 47(2):103-109.
99. Stahl M.M., Neiderud J., Vinge E. Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. JPediatr 1997, 130:1001-1003.
100. Meador K.J., Baker G.A., Browning N., et al. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology 2010, 75(22):1954-1960.
101. Shimoyama R., Ohkubo T., Sugawara K. Monitoring of carbamazepine and carbamazepine 10,11-epoxide in breast milk and plasma by high-performance liquid chromatography. Ann Clin Biochem 2000, 37(Pt 2):210-215.
102. Moretti M.E., Koren G., Verjee Z., et al. Monitoring lithium in breast milk: an individualized approach for breast-feeding mothers. Ther Drug Monit 2003, 25(3):364-366.
103. Viguera A.C., Newport D.J., Ritchie J., et al. Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry 2007, 164(2):342-345.
104. Ohman I., Vitols S., Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000, 41(6):709-713.
105. Steen B., Rane A., Lonnerholm G., et al. Phenytoin excretion in human breast milk and plasma levels in nursed infants. Ther Drug Monit 1982, 4(4):331-334.
106. Matsuda S. Transfer of antibiotics into maternal milk. Biol Res Pregnancy Perinatol 1984, 5(2):57-60.
107. Foulds G., Miller R.D., Knirsch A.K., et al. Sulbactam kinetics and excretion into breast milk in postpartum women. Clin Pharmacol Ther 1985, 38(6):692-696.
108. Celiloglu M., Celiker S., Guven H., et al. Gentamicin excretion and uptake from breast milk by nursing infants. Obstet Gynecol 1994, 84(2):263-265.
109. Festini F., Ciuti R., Taccetti G., et al. Breast-feeding in a woman with cystic fibrosis undergoing antibiotic intravenous treatment. JMatern Fetal Neonatal Med 2006, 19(6):375-376.
110. Uwaydah M., Bibi S., Salman S. Therapeutic efficacy of tobramycin-a clinical and laboratory evaluation. JAntimicrob Chemother 1975, 1(4):429-437.
111. Yoshioka H., Cho K., Takimoto M., et al. Transfer of cefazolin into human milk. JPediatr 1979, 94(1):151-152.
112. Ilett K.F., Hackett L.P., Ingle B., et al. Transfer of probenecid and cephalexin into breast milk. Ann Pharmacother 2006, 40(5):986-989.
113. Takase Z., Shirofuji H., Uchida M. Fundamental and clinical studies of cefuroxime in the field of obstetrics and gynecology. Chemotherapy (Tokyo) 1979, 27(Suppl 6):600-602.
114. Bourget P., Quinquis-Desmaris V., Fernandez H. Ceftriaxone distribution and protein binding between maternal blood and milk postpartum. Ann Pharmacother 1993, 27(3):294-297.
115. Kafetzis D.A., Lazarides C.V., Siafas C.A., et al. Transfer of cefotaxime in human milk and from mother to foetus. JAntimicrob Chemother 1980, 6(Suppl A):135-141.
116. Blanco J.D., Jorgensen J.H., Castaneda Y.S., et al. Ceftazidime levels in human breast milk. Antimicrob Agents Chemother 1983, 23(3):479-480.
117. Sauberan J., Bradley J., Blumer J., et al. Transmission of meropenem in breast milk. Pediatr Infect Dis J 2012, 31:832-834.
118. Bailey D.N., Weibert R.T., Naylor A.J., et al. Astudy of salicylate and caffeine excretion in the breast milk of two nursing mothers. JAnal Toxicol 1982, 6:64-68.
119. Orme M.L., Lewis P.J., De Swiet M., et al. May mothers given warfarin breast-feed their infants?. Br Med J 1977, 1(6076):1564-1565.
120. McEvoy GE, editor. AFHS drug information. 1992. p. 417-26.
121. Richter C., Sitzmann J., Lang P., et al. Excretion of low molecular weight heparin in human milk. Br J Clin Pharmacol 2001, 52(6):708-710.
122. Sanofi-Aventis Canada Inc. Pharmaceutical manufacturer prescribing information: clopidogrel. 2012.